EX-12.1 5 d498571dex121.htm EX-12.1

EX-12.1

Exhibit 12.1

Certification

Pursuant to Section 302

The Sarbanes-Oxley Act of 2002

I, James Garner, certify that:

1. I have reviewed this Annual Report on Form 20-F/A for the fiscal year ended June 30, 2017 (‘Report’) of Kazia Therapeutics Limited (formerly known as Novogen Limited) (the ‘Company’); and

2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report.

/s/ James Garner

James Garner

Chief Executive Officer

Date: December 18, 2017